Siogen, an established global Biotech company residing in Malaysia, is in possession of an innovative and established drug delivery platform that allows problem drugs to be rescued and delivered to the affected site effectively and efficiently. The Siosomes® product platform consists of 6 different segments, SioOnco™, SioBac™, SioRus™, SioFung™, SioVant™ and SioNert™, each of these carrier molecule segments have specific characteristics such as anti cancer (therapeutic or prophylactic), anti ageing, anti infective, inert and adjuvant that will be able to accentuate and provide a synergistic effect to your problem drugs.
Having formed several strong partnerships both locally and internationally, we continue to be very positive and confident of our outlook and are convinced that we will receive much more support from Malaysia and beyond to further enhance our pre-commercialization activities.
SIOGEN, a Malaysian company at heart, positioning itself as a global leader in the ever demanding and challenging world of nano drug targeting and delivery.